Literature DB >> 6440832

GM1 gangliosidosis, type 2: ocular clinicopathologic correlation.

L J Cairns, W R Green, H S Singer.   

Abstract

The clinical and pathological manifestations of a case of juvenile GM1 gangliosidosis are presented and the pathological findings compared with those previously reported for GM1 gangliosidosis in man and in animal models. The most striking finding in the present case was the marked degeneration of the retinal ganglion cell and nerve fiber layers. Although such extensive ganglion cell loss was not observed in any of the other cases reviewed, the presence of multimembranous inclusion bodies in retinal ganglion cells strongly suggests that the pathological process was similar in all cases. Much remains to be learned about the function of gangliosides in the healthy retina and about the pathophysiological consequences of deranged ganglioside metabolism. The many parallels, including those observed in pathological studies, between the human and animal forms of GM1 gangliosidosis allow an optimistic appraisal of the value of further research using the animal models.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6440832     DOI: 10.1007/bf02150632

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  40 in total

1.  Feline GM 1 gangliosidosis: biochemical and ultrastructural comparisons with the disease in man.

Authors:  D F Farrell; H J Baker; R M Herndon; J R Lindsey; G M McKhann
Journal:  J Neuropathol Exp Neurol       Date:  1973-01       Impact factor: 3.685

2.  Late infantile systemic lipidosis. Major monosialogangliosidosis. Delineation of two types.

Authors:  D M Derry; J S Fawcett; F Andermann; L S Wolfe
Journal:  Neurology       Date:  1968-04       Impact factor: 9.910

3.  Retinal pathology in GM 1 gangliosidosis, type II.

Authors:  H H Goebel; J D Fix; W Zeman
Journal:  Am J Ophthalmol       Date:  1973-03       Impact factor: 5.258

4.  Ultrastructure of the retina in Tay-Sach's disease.

Authors:  R B Harcourt; R H Dobbs
Journal:  Br J Ophthalmol       Date:  1968-12       Impact factor: 4.638

5.  Animal models of human ganglioside storage diseases.

Authors:  H J Baker; J A Mole; J R Lindsey; R M Creel
Journal:  Fed Proc       Date:  1976-04

6.  Studies on GM1-gangliosidosis, type II.

Authors:  V Patel; H H Goebel; I Watanabe; W Zeman
Journal:  Acta Neuropathol       Date:  1974       Impact factor: 17.088

7.  Neurotransmitter chemistry in feline GM1 gangliosidosis: a model for human ganglioside storage disease.

Authors:  H S Singer; J T Coyle; D L Weaver; N Kawamura; H J Baker
Journal:  Ann Neurol       Date:  1982-07       Impact factor: 10.422

8.  Chronic GM1 gangliosidosis presenting as dystonia: I. Clinical and pathological features.

Authors:  J E Goldman; D Katz; I Rapin; D P Purpura; K Suzuki
Journal:  Ann Neurol       Date:  1981-05       Impact factor: 10.422

9.  Ocular pathology of bovine GM1 gangliosidosis.

Authors:  B J Sheahan; W J Donnelly; T D Grimes
Journal:  Acta Neuropathol       Date:  1978-02-20       Impact factor: 17.088

10.  Adult GM1 gangliosidosis: clinical and biochemical studies on two patients and comparison to other patients called variant or adult GM1 gangliosidosis.

Authors:  D A Wenger; M Sattler; O T Mueller; G G Myers; R S Schneiman; G W Nixon
Journal:  Clin Genet       Date:  1980-05       Impact factor: 4.438

View more
  2 in total

Review 1.  Optic atrophies in metabolic disorders.

Authors:  Marjan Huizing; Brian P Brooks; Yair Anikster
Journal:  Mol Genet Metab       Date:  2005-09-27       Impact factor: 4.797

2.  Altered expression of β-galactosidase-1-like protein 3 (Glb1l3) in the retinal pigment epithelium (RPE)-specific 65-kDa protein knock-out mouse model of Leber's congenital amaurosis.

Authors:  Joane Le Carré; Daniel F Schorderet; Sandra Cottet
Journal:  Mol Vis       Date:  2011-05-07       Impact factor: 2.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.